7.00
+0.03(+0.43%)
Currency In USD
| Previous Close | 6.97 |
| Open | 7.06 |
| Day High | 7.12 |
| Day Low | 6.87 |
| 52-Week High | 15.84 |
| 52-Week Low | 3.99 |
| Volume | 353,331 |
| Average Volume | 1.65M |
| Market Cap | 331.92M |
| PE | -35 |
| EPS | -0.2 |
| Moving Average 50 Days | 7.08 |
| Moving Average 200 Days | 7.66 |
| Change | 0.03 |
If you invested $1000 in LifeMD, Inc. (LFMD) 10 years ago, it would be worth $15,555.56 as of October 06, 2025 at a share price of $7. Whereas If you bought $1000 worth of LifeMD, Inc. (LFMD) shares 5 years ago, it would be worth $891.72 as of October 06, 2025 at a share price of $7.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk
GlobeNewswire Inc.
Sep 30, 2025 12:00 PM GMT
Ozempic® is now available at this reduced price to eligible self-pay LifeMD patientsNEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced an additional offering through
LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
GlobeNewswire Inc.
Sep 25, 2025 8:06 PM GMT
NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the ROTH 4th Annual Healthcare Opportunities Conference, which will be held October
LifeMD Expands Pharmacy Services with Non-Sterile Compounding to Deliver Personalized, Cost-Efficient Therapies at Scale
GlobeNewswire Inc.
Sep 18, 2025 12:00 PM GMT
Enhanced Affiliated Pharmacy Capabilities Support Specialized Therapies, Seamless Patient Experience, and Margin ExpansionNEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services,